New shot could soothe severe eczema – trial underway
NCT ID NCT07445919
First seen Mar 08, 2026 · Last updated May 22, 2026 · Updated 6 times
Summary
This study tests an investigational drug called SM17, given as a shot under the skin, for adults with moderate-to-severe atopic dermatitis (eczema). About 200 participants will receive either SM17 or a placebo to see if it safely reduces eczema severity and itching. The goal is to find the best dose and confirm whether SM17 can help control this chronic skin condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking University People's Hospital
RECRUITINGBeijing, China
Contact
Contact
Conditions
Explore the condition pages connected to this study.